(VIANEWS) – Shares of Xenetic Biosciences (NASDAQ: XBIO) rose by a staggering 25.64% in 30 days from $0.78 to $0.98 at 11:53 EST on Friday, after two consecutive sessions in a row of gains. NASDAQ is falling 0.86% to $12,610.72, after two sequential sessions in a row of gains.
Xenetic Biosciences’s last close was $0.94, 83.51% below its 52-week high of $5.68.
Today’s last reported volume for Xenetic Biosciences is 63706 which is 11.27% above its average volume of 57251.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the ongoing quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 0.04%, 0.93%, and 3.38%, respectively.
Xenetic Biosciences’s highest amplitude of average volatility was 3.24% (last week), 3.47% (last month), and 3.38% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be overbought (>=80).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.98 at 11:53 EST, way under its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way below its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences (XBIO).